Mitralign
Medical Equipment ManufacturingUnited States51-200 Employees
Mitralign has developed a market-leading transcatheter platform for the treatment of both Tricuspid (Trialign System) and Mitral Valve (Mitralign System) Regurgitation. The Trialign System is currently in the midst of an Early Feasibility Study in the United States and a CE Mark Study in Europe. The Mitral System (Mitralign) has received the CE Mark in Europe.